What is the proper dilution method for a 500 mg meropenem dose for intravenous infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Dilución de Meropenem 500mg para Administración Intravenosa

Para administrar meropenem 500mg por vía intravenosa, reconstituya el vial de 500mg con 10 mL de solución salina normal (0.9% NaCl) estéril, luego diluya en 50-100 mL de solución salina normal para infusión.

Método de Reconstitución y Dilución

Paso 1: Reconstitución del vial

  • Agregue 10 mL de solución salina normal estéril (0.9% NaCl) al vial de 500mg de meropenem
  • Agite hasta disolver completamente el polvo
  • La solución resultante tendrá una concentración aproximada de 50 mg/mL
  • El color variará de incoloro a amarillo, lo cual es normal 1

Paso 2: Dilución para infusión

  • Transfiera la solución reconstituida a una bolsa o frasco de infusión conteniendo 50-100 mL de solución salina normal
  • La concentración final recomendada es de 10-20 mg/mL para máxima estabilidad 2
  • Mezcle suavemente

Parámetros de Administración

Tiempo de infusión:

  • Infusión estándar: 15-30 minutos 1
  • Infusión prolongada: 3 horas (recomendada para patógenos con MIC elevado ≥8 mg/L) 3, 4

Estabilidad de la solución:

  • A concentraciones de 10-20 mg/mL: estable por 12 horas a temperatura ambiente (25°C) 2
  • A concentración de 40 mg/mL: estable solo por 8 horas 2
  • Use la solución inmediatamente después de preparar cuando sea posible

Consideraciones Críticas

Advertencias importantes:

  • No use dextrosa como diluyente; use únicamente solución salina normal 1
  • Cada vial de 500mg contiene 45.1 mg de sodio (1.96 mEq) 1
  • Ajuste la dosis en pacientes con insuficiencia renal (ClCr ≤50 mL/min) 1
  • La solución debe ser transparente; deseche si hay partículas o cambio de color significativo

Dosificación según indicación:

  • Infecciones complicadas: 500mg cada 8 horas 3
  • Infecciones por organismos resistentes: considere 1g cada 8 horas con infusión prolongada 3, 4
  • Neumonía nosocomial/asociada a ventilador: 1g cada 8 horas 3

La evidencia más reciente de guías taiwanesas 3, 4, 5 y la información del fabricante 1 respaldan este método de preparación, que optimiza tanto la estabilidad del fármaco como la efectividad clínica mediante concentraciones plasmáticas adecuadas.

References

3
Guideline

recommendations and guidelines for the treatment of pneumonia in taiwan.

Journal of Microbiology, Immunology and Infection, 2019

Related Questions

How should meropenem be diluted and over what infusion duration should it be administered?
What is meropenem extended infusion and how is it administered?
What should be done if a child receiving appropriate weight‑based meropenem therapy shows no clinical improvement after 48–72 hours?
Can fosphenytoin be co-administered with meropenem?
Can meropenem be diluted directly in 0.9% sodium chloride (normal saline) solution without prior reconstitution with sterile water for injection?
In an intubated insulin‑dependent diabetic patient with a non‑healing leg wound and right‑lower‑lobe infiltrate whose endotracheal tube culture grew methicillin‑resistant Staphylococcus aureus, should we be concerned about a plasmid‑borne AmpC β‑lactamase gene?
In an intubated insulin‑dependent diabetic patient with a non‑healing leg wound, a right lower lobe infiltrate, and an endotracheal tube culture positive for methicillin‑resistant Staphylococcus aureus, are the adeA and adeS genes of any clinical significance?
In an intubated insulin‑dependent diabetic patient with a non‑healing leg wound, right lower‑lobe infiltrate, and endotracheal tube culture growing methicillin‑resistant Staphylococcus aureus (MRSA), what is the clinical significance of a fosA gene?
How should a patient who develops a maculopapular rash with 2‑4 mm discrete lesions and eosinophilia while receiving daptomycin be managed?
What is the phallic stage in Freud's psychosexual development?
What is the recommended target resting heart rate and titration strategy for beta‑blocker therapy in adults?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.